Investors and market participants can look forward to the unveiling of Elevance Health (NYSE: ELV) third quarter financial results on Thursday 17th October 2024. This important update will be made available before market open.
Wall Street financial analysts are foreseeing that the concern is likely to announce an estimated per share $9.66 profit for the quarter. Furthermore, it is anticipated that the company will disclose a total revenue of $43.33 billion during the quarter.
The company's earnings report for the corresponding quarter of the previous year showcased a per-share income of $8.99. This notable figure was achieved due to the company's impressive total revenue of $42.48 billion recorded during that specific period.
Wall street experts have shared their forecasts for the company's annual performance, indicating that they predict the company will achieve a total revenue of $172.72 billion. Additionally, they are expecting the earnings per share for the company to hit profit of $37.26 during the fiscal year.
| Period | EPS Actual |
EPS Growth* |
Revenue Actual |
Revenue Growth* |
|---|---|---|---|---|
| Historical Earnings Insight | ||||
| Q2 2024 | $10.12 | +11.9% | 43.22 B | -0.4% |
| Q1 2024 | $10.64 | +12.5% | 42.27 B | +0.9% |
| Q4 2023 | $5.62 | +7.5% | 42.45 B | +7.0% |
| Q3 2023 | $8.99 | +19.4% | 42.48 B | +7.2% |
| Q2 2023 | $9.04 | +12.4% | 43.38 B | +12.7% |
| *Growth on year-over-year basis | ||||
ELV has scheduled a conference call on 17th October 2024 at 08:30 AM eastern time to discuss the third quarter financial results and other related information.
Elevance Health (ELV) shares traded as low as $484.06 and as high as $497.34 on a day volume of 1.83 million shares, closed Wednesday's regular trading session at $496.96, a gain of 2.71 percent.
